Prognostic significance of muc4 expression in gallbladder carcinoma

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Lee, Hyeon K ^a   Cho, Min Sun ^a   Kim, Tae H ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Gallbladder carcinoma; MUC1; MUC2; MUC4; Prognosis

Indexed keywords

MUCIN 1; MUCIN 2; MUCIN 4;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCIN-1; MUCIN-2; MUCIN-4; PROGNOSIS;

EID: 84867812059     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-224     Document Type: Article

References (37)

1. Manfredi S, Benhamiche AM, Isambert N, Prost P, Jouve JL, Faivre J. Trends in incidence and management of gallbladder carcinoma: a population-based study in France. Cancer 2000, 89:757-762. 10.1002/1097-0142(20000815)89:4<757::AID-CNCR6>3.0.CO;2-H, 10951337.
2. Donohue JH. Present status of the diagnosis and treatment of gallbladder carcinoma. J Hepatobiliary Pancreat Surg 2001, 8:530-534. 10.1007/s005340100021, 11956904.
3. Kim WS, Choi DW, You DD, Ho CY, Heo JS, Choi SH. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg 2010, 14:679-687. 10.1007/s11605-009-1140-z, 20094817.
4. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006, 86:245-278. 10.1152/physrev.00010.2005, 16371599.
5. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004, 4:45-60. 10.1038/nrc1251, 14681689.
6. Yonezawa S, Higashi M, Yamada N, Yokoyama S, Kitamoto S, Kitajima S, Goto M. Mucins in human neoplasms: clinical pathology, gene expression and diagnostic application. Pathol Int 2011, 61:697-716. 10.1111/j.1440-1827.2011.02734.x, 22126377.
7. Vermeer PD, Einwalter LA, Moninger TO, Rokhlina T, Kern JA, Zabner J, Welsh MJ. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 2003, 422:322-326. 10.1038/nature01440, 12646923.
8. Ho SB, Shekels LL, Toribara NW, Kim YS, Lyftogt C, Cherwitz DL, Niehans GA. Mucin gene expression in normal, preneoplastic and neoplastic human gastric epithelium. Cancer Res 1995, 55:2681-2690.
9. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS. Heterogenicity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993, 53:641-651.
10. Higashi M, Yonezawa S, Ho JJ, Tanaka S, Irimura T, Kim YS, Sato E. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology 1999, 30:1347-1355. 10.1002/hep.510300609, 10573510.
11. Yonezawa S, Nakamura A, Horinouchi M, Sato E. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg 2002, 9:328-341. 10.1007/s005340200037, 12353144.
12. Tamada S, Goto M, Nomoto M, Nagata K, Shimizu T, Tanaka S, Sakoda K, Imai K, Yonezawa S. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Pathol Int 2002, 52:713-723. 10.1046/j.1440-1827.2002.01414.x, 12685548.
13. Porchet N, Nguyen VC, Dufosse J, Audie JP, Guyonnet-Duperat V, Gross MS, Denis C, Degand P, Bernheim A, Aubert JP. Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Commun 1991, 175:414-422. 10.1016/0006-291X(91)91580-6, 1673336.
14. Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene 2010, 29:2893-2904. 10.1038/onc.2010.87, 2879972, 20348949.
15. Chaturvedi P, Singh AP, Batra SK. Structure, evolution, and biology of the MUC4 mucin. FASEB J 2008, 22:966-981. 2835492, 18024835.
16. Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM, Moniaux N, Batra SK. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol 2006, 19:1386-1394. 10.1038/modpathol.3800646, 16880776.
17. Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 2005, 18:1295-1304. 10.1038/modpathol.3800445, 15976813.
18. Hanaoka J, Kontani K, Sawai S, Ichinose M, Tezuka N, Inoue S, Fujino S, Ohkubo I. Analysis of MUC4 mucin expression in lung carcinoma cells and its immunogenicity. Cancer 2001, 92:2148-2157. 10.1002/1097-0142(20011015)92:8<2148::AID-CNCR1557>3.0.CO;2-6, 11596032.
19. Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, Hamada T, Osako M, Takao S, Batra SK, Aikou T, Imai K, Yonezawa S. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol 2005, 58:845-852. 10.1136/jcp.2004.023572, 1770880, 16049287.
20. Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, Imai K, Yonezawa S. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 2004, 39:220-229. 10.1002/hep.20031, 14752841.
21. Tamada S, Shibahara H, Higashi M, Goto M, Batra SK, Imai K, Yonezawa S. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res 2006, 12:4257-4264. 10.1158/1078-0432.CCR-05-2814, 16857800.
22. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M. American joint committee on cancer: cancer staging manual 2002, Chicago: Springer, 6.
23. Vandenhaute B, Buisine MP, Debailleul V, Clément B, Moniaux N, Dieu MC, Degand P, Porchet N, Aubert JP. Mucin gene expression in biliary epithelial cells. J Hepatol 1997, 27:1057-1066. 10.1016/S0168-8278(97)80150-X, 9453432.
24. Matull WR, Andreola F, Loh A, Adiguzel Z, Deheragoda M, Qureshi U, Batra SK, Swallow DM, Pereira SP. MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. Br J Cancer 2008, 98:1675-1681. 10.1038/sj.bjc.6604364, 2391120, 18475301.
25. Tsutsumida H, Goto M, Kitajima S, Kubota I, Hirotsu Y, Wakimoto J, Batra SK, Imai K, Yonezawa S. MUC4 expression correlates with poor prognosis in small sized lung adenocarcinoma. Lung Cancer 2007, 55:195-203. 10.1016/j.lungcan.2006.10.013, 17126950.
26. Carraway KL, Perez A, Idris N, Jepson S, Arango M, Komatsu M, Haq B, Price-Schiavi SA, Zhang J, Carraway CA. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol Biol 2002, 71:149-185.
27. Carraway KL, Theodoropoulos G, Kozloski GA, Carothers Carraway CA. Muc4/MUC4 functions and regulation in cancer. Future Oncol 2009, 5:1631-1640. 10.2217/fon.09.125, 2825673, 20001800.
28. Miyahara N, Shoda J, Ishige K, Kawamoto T, Ueda T, Taki R, Ohkohchi N, Hyodo I, Thomas MB, Krishnamurthy S, Carraway KL, Irimura T. MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications. Eur J Cancer 2008, 44:1048-1056. 10.1016/j.ejca.2008.03.007, 18397823.
29. Workman HC, Sweeney C, Carraway KL. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. Cancer Res 2009, 69:2845-2852. 10.1158/0008-5472.CAN-08-2089, 2745945, 19293191.
30. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009, 9:874-885. 10.1038/nrc2761, 2951677, 19935676.
31. Yonezawa S, Goto M, Yamada N, Higashi M, Nomoto M. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 2008, 8:3329-3341. 10.1002/pmic.200800040, 18651706.
32. Ghosh M, Kamma H, Kawamoto T, Koike N, Miwa M, Kapoor VK, Krishnani N, Agrawal S, Ohkohchi N, Todoroki T. MUC 1 core protein as a marker of gallbladder malignancy. Eur J Surg Oncol 2005, 31:891-896. 10.1016/j.ejso.2005.03.008, 15922536.
33. Yamato T, Sasaki M, Watanabe Y, Nakanuma Y. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study. J Pathol 1999, 188:30-37. 10.1002/(SICI)1096-9896(199905)188:1<30::AID-PATH291>3.0.CO;2-Q, 10398137.
34. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, Makuuchi H. MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis. Oncol Rep 2001, 8:485-489.
35. Takagawa M, Muguruma N, Oguri K, Imoto Y, Okamoto K, Ii K, Ito S. Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry. Dig Dis Sci 2005, 50:1410-1413. 10.1007/s10620-005-2854-8, 16114133.
36. Osako M, Yonezawa S, Siddiki B, Huang J, Ho JJ, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrates and core protein in human pancreatic tumors. Cancer 1993, 71:2191-2199. 10.1002/1097-0142(19930401)71:7<2191::AID-CNCR2820710705>3.0.CO;2-X, 8384065.
37. Horinouchi M, Nagata K, Nakamura A, Goto M, Takao S, Sakamoto M, Fukushima N, Miwa A, Irimura T, Imai K, Sato E, Yonezawa. Expression of different glycoforms of membrane mucin(MUC1) and secretory mucin (MUC2, MUC5AC and MUC6) in pancreatic neoplasms. Acta Histochem Cytochem 2003, 36:443-453.